Celgene (CELG) Revenue and Net Income History
Historical revenue, operating income and net income for Celgene (CELG) over the last 10 years. The current TTM revenue for Celgene as of October 20, 2017 is $11.23B.
|Medical||Medical - Biomedical and Genetics||$94.923B||$11.229B|
|Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.|